Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118965832 | 11896583 | 2 | F | 20160902 | 20160107 | 20160907 | PER | US-PFIZER INC-2016003699 | PFIZER | 74.00 | YR | F | Y | 49.90000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118965832 | 11896583 | 1 | PS | CELECOXIB. | CELECOXIB | 1 | Oral | 100 MG, 1X/DAY | Y | 20998 | 100 | MG | CAPSULE, HARD | QD | |||||
| 118965832 | 11896583 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | Y | 20998 | CAPSULE, HARD | ||||||||||
| 118965832 | 11896583 | 3 | C | WARFARIN | WARFARIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118965832 | 11896583 | 1 | Arthritis |
| 118965832 | 11896583 | 2 | Osteoporosis |
| 118965832 | 11896583 | 3 | Thrombosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118965832 | 11896583 | Asthenia | |
| 118965832 | 11896583 | Drug intolerance | |
| 118965832 | 11896583 | Feeling abnormal | |
| 118965832 | 11896583 | Gait disturbance | |
| 118965832 | 11896583 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |